SCHEMBL9809067

SCHEMBL9809067

CCn1c(C)c(SC#N)c(=O)n1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD11B1 P28845 1/20 0.38
GAA P10253 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 2/20 0.37
ALOX15 P16050 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BCHE P06276 1/20 0.37
PTGS2 P35354 1/20 0.37
LMNA P02545 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ABCB1 P08183 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9809114 0.89 CYP19A1 (0.43) CYP19A1MAOAMAOBALDH1A1KDM4E
SCHEMBL9809071 0.86 KDM4E (0.41) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL9809061 0.84 MGLL (0.37) ALDH1A1KDM4EPOLBHSD11B1KMT2A
SCHEMBL9809118 0.84 POLB (0.42) ALDH1A1POLBHSD11B1GAAMEN1
SCHEMBL3882745 0.81 CYP19A1 (0.56) CYP19A1MAOAMAOBALDH1A1KDM4E
SCHEMBL9809121 0.81 POLB (0.40) ALDH1A1POLBHSD11B1GAAMEN1
SCHEMBL536896 0.80 CYP19A1 (0.55) CYP19A1MAOAMAOBALDH1A1KDM4E
SCHEMBL9809076 0.80 ALDH1A1 (0.44) ALDH1A1KDM4EPOLBMAPK1GAA
SCHEMBL9809117 0.75 CYP19A1 (0.45) CYP19A1MAOAMAOBALDH1A1KDM4E
SCHEMBL6260403 0.73 BCHE (0.63) ALDH1A1KDM4EPOLBHSD11B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5063245-A Hormone inhibitors NOVA PHARMACEUTICAL CORPORATION (US) 1991-11-05 US disclosed